AXSOME THERAPEUTICS INC. - COMMON STOCK
121.91
14-مارس-25 16:45:00
15 متأخرة بدقائق
الأسهم
+0.26
+0.21%
نطاق اليوم
120.52 - 123.47
ISIN
N/A
المصدر
NASDAQ
-
Axsome Therapeutics Initiates SYMPHONY Phase 3 Trial of AXS-12 in Narcolepsy
16 سبتمبر 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
14 سبتمبر 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
23 أغسطس 2021 06:00:00 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
09 أغسطس 2021 07:05:00 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Second Quarter 2021 Financial Results on August 9, 2021
15 يوليو 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics Announces Planned NDA Submission for AXS-14 for the Management of Fibromyalgia
15 يونيو 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
10 مايو 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
07 مايو 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report First Quarter 2021 Financial Results on May 10, 2021
27 أبريل 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
26 أبريل 2021 06:00:00 بحسب Nasdaq GlobeNewswire
-
01 مارس 2021 07:00:01 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
19 فبراير 2021 07:00:00 بحسب Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on March 1, 2021
16 فبراير 2021 07:00:02 بحسب Nasdaq GlobeNewswire